PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 30543144-3 2019 Compared with co-treatment with NGF and fluvoxamine, p-Akt levels were higher than the values without fluvoxamine. Fluvoxamine 40-51 AKT serine/threonine kinase 1 Rattus norvegicus 55-58 30543144-6 2019 Fluvoxamine also improved the decrease in the NGF-induced p-Akt level caused by DEX. Fluvoxamine 0-11 AKT serine/threonine kinase 1 Rattus norvegicus 60-63 30543144-9 2019 These results indicate that the improvement effects of fluvoxamine on NGF-induced neurite outgrowth inhibition by DEX may be attributable to the phosphorylation of Akt and the sigma-1 receptor. Fluvoxamine 55-66 AKT serine/threonine kinase 1 Rattus norvegicus 164-167 28410959-4 2017 Chronic haloperidol (1mg/kg) +fluvoxamine (10mg/kg) treatment increased TrkB receptor and BDNF expression levels, and the phosphorylation of AKT/CREB/GSK-3beta, compared to the individual drugs in rat brain. Fluvoxamine 30-41 AKT serine/threonine kinase 1 Rattus norvegicus 141-144 28410959-6 2017 In primary neuronal cell cultures, pretreatment with a selective PI3K inhibitor abolished the haloperidol+fluvoxamine-induced phosphorylation of AKT and GSK-3beta, but did not affect the upregulation of CREB phosphorylation. Fluvoxamine 106-117 AKT serine/threonine kinase 1 Rattus norvegicus 145-148 27056295-6 2017 Fluvoxamine stimulation in these cells also activated nitric oxide production that was blocked by sigma1-receptor knockdown or Akt inhibition. Fluvoxamine 0-11 AKT serine/threonine kinase 1 Rattus norvegicus 127-130 27056295-7 2017 Similarly, in the postischemic rat kidney, sigma1-receptor activation by fluvoxamine triggered the Akt-nitric oxide synthase signaling pathway, resulting in time- and isoform-specific endothelial and neuronal nitric oxide synthase activation and nitric oxide production. Fluvoxamine 73-84 AKT serine/threonine kinase 1 Rattus norvegicus 99-102 21044620-0 2011 Sigma-1 receptor stimulation with fluvoxamine activates Akt-eNOS signaling in the thoracic aorta of ovariectomized rats with abdominal aortic banding. Fluvoxamine 34-45 AKT serine/threonine kinase 1 Rattus norvegicus 56-59 21044620-6 2011 Fluvoxamine treatment also significantly restored pressure overload-induced impaired Akt phosphorylation and stimulated eNOS protein expression as well as Akt-mediated eNOS phosphorylation (Ser1177). Fluvoxamine 0-11 AKT serine/threonine kinase 1 Rattus norvegicus 85-88 21044620-6 2011 Fluvoxamine treatment also significantly restored pressure overload-induced impaired Akt phosphorylation and stimulated eNOS protein expression as well as Akt-mediated eNOS phosphorylation (Ser1177). Fluvoxamine 0-11 AKT serine/threonine kinase 1 Rattus norvegicus 155-158 19995565-13 2010 SIGNIFICANCE: This study demonstrates that fluvoxamine treatment rapidly increased phosphorylation of Akt-1. Fluvoxamine 43-54 AKT serine/threonine kinase 1 Rattus norvegicus 102-107 20722474-8 2010 Fluvoxamine treatment significantly restored PO-induced impaired eNOS and Akt activity in the LV. Fluvoxamine 0-11 AKT serine/threonine kinase 1 Rattus norvegicus 74-77 20722474-10 2010 Fluvoxamine treatment protects PO-induced cardiac injury via upregulation of Sig-1R and stimulation of Sig-1R-mediated Akt-eNOS signaling in ovariectomized rats. Fluvoxamine 0-11 AKT serine/threonine kinase 1 Rattus norvegicus 119-122 19995565-0 2010 Fluvoxamine and sigma-1 receptor agonists dehydroepiandrosterone (DHEA)-sulfate induces the Ser473-phosphorylation of Akt-1 in PC12 cells. Fluvoxamine 0-11 AKT serine/threonine kinase 1 Rattus norvegicus 118-123 19995565-7 2010 Here, we examined whether fluvoxamine (FLV) activated Akt-1 and increased phosphorylation of Akt-1 via sigma-1 receptor in PC12 cells. Fluvoxamine 26-37 AKT serine/threonine kinase 1 Rattus norvegicus 54-59 19995565-7 2010 Here, we examined whether fluvoxamine (FLV) activated Akt-1 and increased phosphorylation of Akt-1 via sigma-1 receptor in PC12 cells. Fluvoxamine 26-37 AKT serine/threonine kinase 1 Rattus norvegicus 93-98 19995565-7 2010 Here, we examined whether fluvoxamine (FLV) activated Akt-1 and increased phosphorylation of Akt-1 via sigma-1 receptor in PC12 cells. Fluvoxamine 39-42 AKT serine/threonine kinase 1 Rattus norvegicus 54-59 19995565-7 2010 Here, we examined whether fluvoxamine (FLV) activated Akt-1 and increased phosphorylation of Akt-1 via sigma-1 receptor in PC12 cells. Fluvoxamine 39-42 AKT serine/threonine kinase 1 Rattus norvegicus 93-98